Doxorubicin Hydrochloride
Product Images NDC 0069-3031

15 FDA label images from Pfizer Laboratories Div Pfizer Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 0069-3031). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Doxorubicin 01)

Chemical Structure (Doxorubicin 01)
Chemical structure of Doxorubicin Hydrochloride showing its molecular formula C27H29NO11•HCl and molecular weight 579.99. The diagram illustrates the arrangement of rings and functional groups characteristic of the compound.*
FDA Label Image

Figure 1 (Doxorubicin 02)

Figure 1 (Doxorubicin 02)
A hazard ratio plot comparing six clinical trials evaluating Doxorubicin Hydrochloride versus CMF treatment. The x-axis shows hazard ratios from 0 to 2 with a boundary of non-inferiority indicated by a dotted line at 1.06. Each trial is represented by a square and horizontal confidence interval bars, with a diamond symbol summarizing the combined result of six Doxorubicin-based studies.*
FDA Label Image

Figure 2 (Doxorubicin 03)

Figure 2 (Doxorubicin 03)
A forest plot chart showing hazard ratios with 95% confidence intervals for different clinical trials comparing the effectiveness of Doxorubicin Hydrochloride-based treatment versus CMF. Individual trials are listed on the Y-axis, and hazard ratios range from 0 to 2 on the X-axis, illustrating comparisons of treatment outcomes.*
FDA Label Image

Logo (Doxorubicin 04)

FDA Label Image

Logo (Doxorubicin 04a)

FDA Label Image

Principal Display Panel (10 mg/5 mL Vial Label)

Principal Display Panel (10 mg/5 mL Vial Label)
Label for Doxorubicin Hydrochloride Injection 2 mg/mL, showing a 10 mg/5 mL concentration on the vial. The label indicates it is a single-dose, sterile isotonic solution for intravenous use only. It includes storage instructions to refrigerate between 2°C and 8°C, caution as a cytotoxic agent, and is labeled as Rx only. Manufactured by Pfizer Laboratories, Division of Pfizer Inc, and made in Australia.*
FDA Label Image

Principal Display Panel (10 mg/5 mL Vial Carton)

Principal Display Panel (10 mg/5 mL Vial Carton)
Packaging label for Doxorubicin Hydrochloride Injection 10 mg/5 mL (2 mg/mL) by Pfizer Laboratories Div Pfizer Inc. The label indicates a sterile, isotonic solution for intravenous use only, single-dose with a Cytosafe Vial. It includes storage instructions, caution as a cytotoxic agent, and batch/expiration details. The product is made in Australia and distributed by Pfizer Labs, New York, NY.*
FDA Label Image

Principal Display Panel (20 mg/10 mL Vial Label)

Principal Display Panel (20 mg/10 mL Vial Label)
Label of Doxorubicin Hydrochloride Injection 20 mg/10 mL (2 mg/mL) single-dose vial from Pfizer Laboratories. The label indicates it is a sterile, isotonic solution for intravenous use only, stored refrigerated between 2° and 8°C, and cautions that it is a cytotoxic agent. Made in Australia and distributed by Pfizer Labs.*
FDA Label Image

Principal Display Panel (20 mg/10 mL Vial Carton)

Principal Display Panel (20 mg/10 mL Vial Carton)
Packaging label for Doxorubicin Hydrochloride Injection 20 mg/10 mL (2 mg/mL) by Pfizer Laboratories Division. The label indicates the product is a sterile, isotonic solution for intravenous use only, supplied in a Cytosafe vial. The label includes storage instructions, dosage information, a barcode, and a caution that the product is cytotoxic.*
FDA Label Image

Principal Display Panel (50 mg/25 mL Vial Label)

Principal Display Panel (50 mg/25 mL Vial Label)
Label for Doxorubicin Hydrochloride Injection 2 mg/mL, supplied as 50 mg/25 mL single-dose vial. The label indicates it is a sterile, isotonic solution for intravenous use only, with caution for cytotoxicity. Manufactured in Australia and distributed by Pfizer Laboratories Division of Pfizer Inc.*
FDA Label Image

Principal Display Panel (50 mg/25 mL Vial Carton)

Principal Display Panel (50 mg/25 mL Vial Carton)
Packaging label for Doxorubicin Hydrochloride Injection, 50 mg/25 mL (2 mg/mL), a single-dose vial labeled for intravenous use. The label shows storage instructions, product strength, dosage form, and manufacturer as Pfizer Laboratories Division of Pfizer Inc. It includes cautionary text noting it is a cytotoxic agent and dispensing information.*
FDA Label Image

Principal Display Panel (150 mg/75 mL Vial Label)

Principal Display Panel (150 mg/75 mL Vial Label)
Label for Doxorubicin Hydrochloride Injection 2 mg/mL, branded as Cytosafe Vial, from Pfizer Laboratories Div Pfizer Inc. The label indicates a 150 mg/75 mL concentration in a multiple-dose vial for intravenous use only. Storage instructions specify refrigeration between 2° and 8°C, protecting from light. The label includes caution for cytotoxicity and notes the solution's pH adjustment and sodium chloride content.*
FDA Label Image

Principal Display Panel (150 mg/75 mL Vial Carton)

Principal Display Panel (150 mg/75 mL Vial Carton)
Packaging label for Doxorubicin Hydrochloride Injection 150 mg/75 mL (2 mg/mL) multiple-dose vial. Label shows the product name, strength, dosage form, and cautions that it is for intravenous use only and a cytotoxic agent. The labeler is Pfizer Laboratories Div Pfizer Inc, with manufacturing in Australia. Storage instructions recommend refrigeration between 2° and 8°C with protection from light.*
FDA Label Image

Principal Display Panel (200 mg/100 mL Vial Label)

Principal Display Panel (200 mg/100 mL Vial Label)
Label for Doxorubicin Hydrochloride Injection 200 mg/100 mL (2 mg/mL) sterile isotonic solution in a multiple-dose vial, marked for intravenous use only. The label includes storage instructions to keep refrigerated between 2° and 8°C and protects from light. It is distributed by Pfizer Labs, Division of Pfizer Inc. The product is labeled as cytotoxic and made in Australia.*
FDA Label Image

Principal Display Panel (200 mg/100 mL Vial Carton)

Principal Display Panel (200 mg/100 mL Vial Carton)
Packaging label for Doxorubicin Hydrochloride Injection 200 mg/100 mL (2 mg/mL) multiple-dose vial by Pfizer Laboratories Div Pfizer Inc. The label includes storage instructions, dosage info, caution as a cytotoxic agent, and is marked for intravenous use only. It features the Pfizer Injectables logo and states the product is made in Australia.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.